medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 620

<< Back Next >>

Rev Med Cos Cen 2016; 73 (620)

Estenosis aórtica

Sánchez VA, Uribe CJC
Full text How to cite this article

Language: Spanish
References: 12
Page: 433-438
PDF size: 181.63 Kb.


Key words:

No keywords

ABSTRACT

Aortic Stenosis is the main valve disease in the western world and the most common cause of heart valve operations. Aortic stenosis occurs primarily due to a degenerative calcification of the aortic cusps most frequently in the context of a patient with congenital bicuspid aortic valve. Currently, no medical therapies are able to modify disease progression, however the advances in knowledge about the pathophysiology and genetics involved could lead to new treatments. Nowadays several drugs for this purpose are being studied and the only treatments that improve the outcome in these patients are still the aortic replacement and aortic implantation.


REFERENCES

  1. Chairperson AV, et al. Guidelines on the management of valvular heart disease 2012. European Heart Journal 2012; 33:2451-2496.

  2. Greve A, et al. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis. AHA Circulation 2012;125:346-353.

  3. Hung MY, Witztum JL, Tsimikas S. New therapeutic targets for calcific aortic valve stenosis. JACC 2014;63:478-480.

  4. Longo D. et al. Harrison, Principios de Medicina Interna. Cardiopatias Valvulares. 2012. Edicion 18, Vol 2, Capitulo 237: 1929-1950.

  5. Mann D. et al. Braunwald’s Heart Disease. Valvular Heart Disease. 2015. 10th Edition, Vol 2, Chapter 63:1446-1523.

  6. Martinsson A, et al. Temporal trends in the incidence and prognosis of aortic stenosis. AHA Circulation 2015; 131: 988-994.

  7. Nishimura RA, Otto C, Bonow RO, Carabello BA, Erwin III JP, Guyton RA, O’Gara PT, et al. 2014 AHA/ ACC Guideline for the management of patients with valvular heart disease. JACC 2014; 63:e57-185.

  8. Otto C, Pendergast B. Aortic-valve stenosis - from patients at risk to severe valve obstruction. N Eng J Med. 2014;371:744-756.

  9. Pawade T, Newby DE, Dweck MR. Calcification in aortic stenosis. JACC 2015; 66:561-577.

  10. Pibarot P, Dumesnil JG. Improving assessment of aortic stenosis. JACC 2012: 60:169-180.

  11. Smith CR, Leon MB, Mack MJ, Miller C, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in highrisk patients. N Eng J Med 2011; 364:2187-2198.

  12. Thanassoulis G. et al. Genetic associations with valvular calcification and aortic stenosis. N Eng J Med 2013; 368:503-512.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2016;73